Modular approach to comprehensive oncological decision support |
Daniel Schneider |
Innovation Center Computer Assisted Surgery, Leipzig University |
PLCO |
Jul 22, 2021 |
PLCO-813 |
Diabetes risk reduction diet and the risk of pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Guo-Chao Zhong |
The Second Affiliated Hospital of Chongqing Medical University |
PLCO |
Jul 22, 2021 |
PLCO-812 |
Racial Disparities in Risk Group at Presentation and Access to Treatment for Prostate, Lung, Colorectal and Ovarian Cancer: Insights from the PLCO Cancer Screening Trial |
Edward Dee |
Memorial Sloan Kettering Cancer Center |
PLCO |
Jul 22, 2021 |
PLCO-796 |
Viral exposure signatures in hepatocellular carcinoma |
Katherine McGlynn |
National Cancer Institute |
PLCO |
Jul 21, 2021 |
2021-0015 |
Validation of plasma biomarker panels for the early detection of pancreatic cancer |
Brian Haab |
Van Andel Institute |
PLCO |
Jul 21, 2021 |
2021-0017 |
Using machine learning to understand demographic differences when predicting ovarian cancer |
Devanshi Kothari |
Independent |
PLCO |
Jul 15, 2021 |
PLCO-806 |
Understanding the Persistence Breast Cancer Racial Disparities |
Kelly Hirko |
Michigan State University |
PLCO |
Jul 15, 2021 |
PLCO-809 |
Establishing risk factors for bladder cancer to inform prevention: a pooled analysis of prospective studies from the NCI Cohort Consortium |
Roger Milne |
Cancer Council Victoria |
PLCO |
Jul 15, 2021 |
PLCO-810 |
A Retrospective Study for Construction and Evaluation of Cancer Screening Models from the PLCO Trial: Pancreatic, Prostate, Lung, Colorectal, and Ovarian Cohorts |
James Long |
University of Texas MD Anderson Cancer Center |
PLCO |
Jul 15, 2021 |
PLCO-808 |
System for searching similar patients as supportive tool for clinical decision |
Anton Kovac |
Siemens Healthineers |
PLCO |
Jul 15, 2021 |
PLCO-807 |
Association of sex steroid hormones and biliary tract cancers in men and women |
Jill Koshiol |
National Cancer Institute |
PLCO |
Jul 13, 2021 |
2021-0010 |
Serum concentrations of per- and polyfluoroalkyl substances and breast cancer risk among postmenopausal women: A nested case-control study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Vicky Chang |
Occupational and Environmental Epidemiology Branch, DCEG, NCI |
PLCO |
Jul 9, 2021 |
2021-0016 |
Marital status and all cause and cause-specific mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. |
danhua wang |
Department of Public Health and Preventive Medicine, Kangda College of Nanjing Medical University |
PLCO |
Jul 2, 2021 |
PLCO-804 |
Identifying DNA methylation patterns associated with Multiple Sclerosis |
Rodney Lea |
The University of Newcastle |
PLCO |
Jul 2, 2021 |
PLCO-802 |
Diet and Lung Cancer Risk |
Yin Zhang |
West China School of Medicine and West China Hospital, Sichuan University |
PLCO |
Jul 2, 2021 |
PLCO-800 |
An analysis into the association between diet, BMI, diabetes, lifestyle factors and patient demographics on thyroid cancer incidence and mortality. |
Tharakeswari Selvakumar |
Rutgers New Jersey Medical School |
PLCO |
Jun 21, 2021 |
PLCO-795 |
Provide patients with an improved cancer screening recommendation |
Sebastian Roth |
Ludwig-Maximilians-Universität Munich - Chair for Mobile and Distributed Systems |
PLCO |
Jun 21, 2021 |
PLCO-798 |
Integrating genetic susceptibility, blood biomarkers, and traditional factors to develop predictive models for colorectal adenoma and cancer |
Dong Hang |
Nanjing Medical University |
PLCO |
Jun 21, 2021 |
PLCO-793 |
Validation of prognostic models of lung cancer |
Thomas Callender |
University College London |
PLCO |
Jun 21, 2021 |
PLCO-801 |
Prospective study of DNA repair functional assays and risk of lung cancer |
Zvi Livneh |
Weizmann Institute of Science |
PLCO |
Jun 14, 2021 |
2021-0018 |